Valérie Delecroix
Clinique Mutualiste de l'Estuaire(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Ovarian cancer diagnosis and treatment, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer, Telomeres, Telomerase, and Senescence
Most-Cited Works
- → Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial(2022)291 cited
- → Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study(2015)19 cited
- → Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial(2025)9 cited
- → Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)(2024)3 cited